Literature DB >> 7031016

A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine.

P Louis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031016     DOI: 10.1111/j.1526-4610.1981.hed2106235.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  15 in total

Review 1.  Prophylaxis of migraine headache.

Authors:  Tamara Pringsheim; W Jeptha Davenport; Werner J Becker
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

Review 2.  Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors:  K J Tietze; M L Schwartz; P H Vlasses
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

Review 3.  Influence of vasospasm on visual function.

Authors:  P Gasser; J Flammer
Journal:  Doc Ophthalmol       Date:  1987-05       Impact factor: 2.379

4.  Migraine Prophylaxis: A pharmacologic approach.

Authors:  I Danys
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

5.  Effect of flunarizine on pituitary secretion by healthy men and in woman with migraine.

Authors:  E Maestri; G C Manzoni; G Marchesi; L Camellini; G Rossi; G Veneri; A Gnudi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors:  I Jansen; P Tfelt-Hansen; L Edvinsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 8.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

9.  [Drug treatment as migraine prophylaxis.].

Authors:  H C Diener; A Ziegler
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

10.  [Therapy for migraine-the current state of the art and perspectives.].

Authors:  D Soyka
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.